Tyra Biosciences, Inc. (TYRA) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$95.14M | -36.4% |
| 2024 | -$69.77M | -39.2% |
| 2023 | -$50.14M | +0.3% |
| 2022 | -$50.28M | -111.8% |
| 2021 | -$23.75M | -205.9% |
| 2020 | -$7.76M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$95.14M | -36.4% |
| 2024 | -$69.77M | -39.2% |
| 2023 | -$50.14M | +0.3% |
| 2022 | -$50.28M | -111.8% |
| 2021 | -$23.75M | -205.9% |
| 2020 | -$7.76M | — |